New Late-Breaking Data Show Equivalent Outcomes with Shorter Durations of Anti-Clotting Drugs for XIENCE™ Stent Patients with High Bleeding Risk

Media coverage

• Title	New Late-Breaking Data Show Equivalent Outcomes with Shorter Durations of Anti-Clotting Drugs for XIENCE™ Stent Patients with High Bleeding Risk
  Media name/outlet	CompanyNewsHQ
  Country/Territory	United Kingdom
  Date	15/10/20
  URL	https://www.companynewshq.com/company-news/medical-device-company-news/new-late-breaking-data-show-equivalent-outcomes-with-shorter-durations-of-anti-clotting-drugs-for-xience-stent-patients-with-high-bleeding-risk/
  Persons	Roxana Mehran,

• Title	TCT: New Late-Breaking Data Show Equivalent Outcomes with Shorter Durations of Anti-Clotting Drugs for Xience Stent Patients with High Bleeding Risk
  Media name/outlet	Cath Lab Digest
  Country/Territory	United States
  Date	15/10/20
  URL	https://www.cathlabdigest.com/content/tct-new-late-breaking-data-show-equivalent-outcomes-shorter-durations-anti-clotting-drugs-xience-stent-patients-high-bleeding-risk
  Persons	Roxana Mehran,

• Title	New Late-Breaking Data Show Equivalent Outcomes with Shorter Durations of Anti-Clotting Drugs for XIENCE™ Stent Patients with High Bleeding Risk
  Media name/outlet	Abbott Laboratories
  Country/Territory	United States
  Date	15/10/20
  URL	https://abbott.mediaroom.com/2020-10-15-New-Late-Breaking-Data-Show-Equivalent-Outcomes-with-Shorter-Durations-of-Anti-Clotting-Drugs-for-XIENCE-Stent-Patients-with-High-Bleeding-Risk
  Persons	Roxana Mehran,